Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 10470708.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Among 14 randomised patients with proliferative lupus nephritis, monthly intravenous immunoglobulin maintained remission over 18 months, similar to standard intravenous cyclophosphamide treatment. Pulsed immunoglobulin may be a useful alternative therapy in lupus nephritis.
Medical subject headings
- Cyclophosphamide
- Immunoglobulins, Intravenous
- Immunosuppressive Agents
- Lupus Nephritis